title: Initiating dopaminergic treatment in Parkinson's disease.
authors.affiliation: The Edmond J Safra Program in Parkinson's Disease, University Health Network, Toronto, ON, Canada; Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON M5S 2J7, Canada. Electronic address: lang@uhnres.utoronto.ca.
authors.forename: Anthony E
authors.initials: AE
authors.lastname: Lang
authors.affiliation: The Edmond J Safra Program in Parkinson's Disease, University Health Network, Toronto, ON, Canada; Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON M5S 2J7, Canada.
authors.forename: Connie
authors.initials: C
authors.lastname: Marras
mesh_terms: D000818:Animals; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D008996:Monoamine Oxidase Inhibitors; D007980:Levodopa